Nerve growth factor and diabetic neuropathy

被引:3
作者
Castellano, O [1 ]
Martinez-Marti, L [1 ]
Gomez-Fernandez, L [1 ]
机构
[1] CIREN, La Habana 11300, Cuba
关键词
diabetic neuropathy; nervous growth factor; neurotrophic factors;
D O I
10.33588/rn.26154.98029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. The progress made by contemporary neurobiology opens new horizons both for study and for treatment of disorders of the nervous system. At the present time rue are in the age of growth factors. these are molecules which affect survival, development and the normal functioning of cell populations. Development. One of the most widely studied growth factors is nervous growth factor (NGF) which is necessary for normal life of various types of neurones, including sensory nerves and nerves derived from the neural crests. Diabetic neuropathy, worldwide a major neurological disorder is primarily characterized by involvement of the fine fibres for temperature and pain perception and also by a variety autonomic disorders. The great dependence of sensory and sympathetic nerves on NGF, the quantity of results which show alterations in the levels of neurotrophic factors in diabetic neuropathy (DN), and the encouraging experimental and clinical results of using NGF as a new alternative to treatment with DN, were the basic reasons which led rls to do this study Conclusions. We star red by considering neurotrophic factors, especially NGF and its connection with DN disorders and its clinical applications, we made a summary of the main findings in this field to date [REV NEUROL 1998; 26; 1032-9].
引用
收藏
页码:1032 / 1039
页数:8
相关论文
共 42 条
  • [1] NERVE GROWTH-FACTOR PREVENTS TOXIC NEUROPATHY IN MICE
    APFEL, SC
    LIPTON, RB
    AREZZO, JC
    KESSLER, JA
    [J]. ANNALS OF NEUROLOGY, 1991, 29 (01) : 87 - 90
  • [2] NERVE GROWTH-FACTOR PREVENTS EXPERIMENTAL CISPLATIN NEUROPATHY
    APFEL, SC
    AREZZO, JC
    LIPSON, L
    KESSLER, JA
    [J]. ANNALS OF NEUROLOGY, 1992, 31 (01) : 76 - 80
  • [3] NERVE GROWTH-FACTOR ADMINISTRATION PROTECTS AGAINST EXPERIMENTAL DIABETIC SENSORY NEUROPATHY
    APFEL, SC
    AREZZO, JC
    BROWNLEE, M
    FEDEROFF, H
    KESSLER, JA
    [J]. BRAIN RESEARCH, 1994, 634 (01) : 7 - 12
  • [4] APFEL SC, 1997, IN PRESS RANDOMIZED
  • [5] DIABETIC NEUROPATHY, NERVE GROWTH-FACTOR AND OTHER NEUROTROPHIC FACTORS
    BREWSTER, WJ
    FERNYHOUGH, P
    DIEMEL, LT
    MOHIUDDIN, L
    TOMLINSON, DR
    [J]. TRENDS IN NEUROSCIENCES, 1994, 17 (08) : 321 - 325
  • [6] EXPRESSION OF NEUROPEPTIDES IN EXPERIMENTAL DIABETES - EFFECTS OF TREATMENT WITH NERVE GROWTH-FACTOR OR BRAIN-DERIVED NEUROTROPHIC FACTOR
    DIEMEL, LT
    BREWSTER, WJ
    FERNYHOUGH, P
    TOMLINSON, DR
    [J]. MOLECULAR BRAIN RESEARCH, 1994, 21 (1-2): : 171 - 175
  • [7] SCHWANN-CELL NERVE GROWTH-FACTOR RECEPTOR EXPRESSION DURING INITIATION OF REMYELINATION
    FAN, X
    GELMAN, BB
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 31 (01) : 58 - 67
  • [8] FARADJI V, 1990, ACTA NEUROL SCAND, V81, P402
  • [9] DEFICITS IN SCIATIC-NERVE NEUROPEPTIDE CONTENT COINCIDE WITH A REDUCTION IN TARGET TISSUE NERVE GROWTH-FACTOR MESSENGER-RNA IN STREPTOZOTOCIN-DIABETIC RATS - EFFECTS OF INSULIN-TREATMENT
    FERNYHOUGH, P
    DIEMEL, LT
    BREWSTER, WJ
    TOMLINSON, DR
    [J]. NEUROSCIENCE, 1994, 62 (02) : 337 - 344
  • [10] EFFECT OF 4-METHYLCATECHOL ON SCIATIC-NERVE GROWTH-FACTOR LEVEL AND MOTOR-NERVE CONDUCTION-VELOCITY IN EXPERIMENTAL DIABETIC NEUROPATHIC PROCESS IN RATS
    HANAOKA, Y
    OHI, T
    FURUKAWA, S
    FURUKAWA, Y
    HAYASHI, K
    MATSUKURA, S
    [J]. EXPERIMENTAL NEUROLOGY, 1992, 115 (02) : 292 - 296